| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $31,124,887 | 6 | 100 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 0 | $0 | 1 | $747,135 | $-747,135 |
| Wyatt Christopher F. | SVP & Controller | 0 | $0 | 1 | $2.02M | $-2.02M |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | 0 | $0 | 2 | $2.75M | $-2.75M |
| Berres Jennifer | SVP & Chief Human Res. Officer | 0 | $0 | 1 | $4.13M | $-4.13M |
| HAZEN SAMUEL N | CEO | 0 | $0 | 1 | $21.48M | $-21.48M |
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, …
Over the last 12 months, insiders at HCA Healthcare, Inc. have bought $0 and sold $31.12M worth of HCA Healthcare, Inc. stock.
On average, over the past 5 years, insiders at HCA Healthcare, Inc. have bought $3.17M and sold $27.51M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 325 shares for transaction amount of $64,565 was made by Elcan Patricia F () on 2022‑07‑25.
| 2026-02-18 | Sale | McAlevey Michael R | EVP & Chief Legal & Admin Off. | 1,694 0.0008% | $533.37 | $903,537 | -19.74% | |
| 2026-02-11 | Sale | Wyatt Christopher F. | SVP & Controller | 4,000 0.0017% | $505.00 | $2.02M | -19.09% | |
| 2026-02-11 | Sale | Berres Jennifer | SVP & Chief Human Res. Officer | 8,020 0.0034% | $514.58 | $4.13M | -19.09% | |
| 2026-02-03 | Sale | HAZEN SAMUEL N | CEO | 42,877 0.0189% | $501.04 | $21.48M | -13.80% | |
| 2026-02-03 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 1,500 0.0007% | $498.09 | $747,135 | -13.80% | |
| 2025-11-05 | Sale | McAlevey Michael R | EVP & Chief Legal & Admin Off. | 3,892 0.0017% | $473.79 | $1.84M | -1.96% | |
| 2025-09-08 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 3,836 0.0016% | $418.84 | $1.61M | +5.71% | |
| 2025-05-13 | Sale | Foster Jon M | EVP and COO | 15,698 0.0065% | $369.32 | $5.8M | +20.31% | |
| 2025-02-14 | Sale | Berres Jennifer | SVP & Chief Human Res. Officer | 9,533 0.0038% | $322.59 | $3.08M | +25.13% | |
| 2024-11-14 | Sale | Billington Phillip G | SVP-Internal Audit Services | 3,897 0.0016% | $350.00 | $1.36M | +3.55% | |
| 2024-11-14 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 1,474 0.0006% | $357.99 | $527,677 | +3.55% | |
| 2024-11-14 | Sale | Akdamar Erol R | Group President | 2,900 0.0012% | $353.00 | $1.02M | +3.55% | |
| 2024-09-12 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 8,358 0.0032% | $385.42 | $3.22M | -9.29% | |
| 2024-07-31 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 2,987 0.0011% | $363.51 | $1.09M | -2.88% | |
| 2024-07-29 | Sale | Wyatt Christopher F. | SVP & Controller | 4,000 0.0015% | $360.20 | $1.44M | -1.71% | |
| 2024-07-29 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 1,864 0.0007% | $359.92 | $670,891 | -1.71% | |
| 2024-07-29 | Sale | Reiner Deborah M | SVP - Mktg. & Communications | 3,314 0.0013% | $359.96 | $1.19M | -1.71% | |
| 2024-07-25 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 1,857 0.0007% | $355.05 | $659,328 | +0.42% | |
| 2024-05-16 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 3,204 0.0012% | $326.30 | $1.05M | +4.64% | |
| 2024-05-15 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 1,863 0.0007% | $326.18 | $607,673 | +3.24% |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | 8853 0.0042% | $4.1M | 1 | 2 | +2.53% |
| BANK OF AMERICA CORP /DE/ | 2652364 1.2697% | $1.23B | 45 | 51 | <0.0001% | |
| FRIST THOMAS F JR | 471378 0.2257% | $218.18M | 8 | 1 | +1.98% | |
| FRIST PATRICIA C | 10 percent owner | 389855 0.1866% | $180.45M | 5 | 0 | +7.64% |
| Elcan Patricia F | 89337 0.0428% | $41.35M | 2 | 0 | +13.15% | |
| Vallarino Juan | SVP- Employer&Payer Engagement | 61036 0.0292% | $28.25M | 1 | 13 | <0.0001% |
| Davis Jana Joustra | SVP - Mktg. & Corp. Affairs | 26378 0.0126% | $12.21M | 1 | 14 | <0.0001% |
| MEYERS GEOFFREY G | director | 19167 0.0092% | $8.87M | 1 | 0 | <0.0001% |
| ROWE JOHN W | director | 18133 0.0087% | $8.39M | 1 | 0 | +33.57% |
| Light Jay O | director | 14167 0.0068% | $6.56M | 1 | 0 | <0.0001% |
| HOLLIDAY CHARLES O JR | director | 8000 0.0038% | $3.7M | 2 | 0 | <0.0001% |
| Smith Andrea B | 2239 0.0011% | $1.04M | 1 | 0 | +0.28% | |
| Sowell Joseph A III | SVP; Chief Development Officer | 0 0% | $0 | 1 | 9 | <0.0001% |
| Increased Positions | 688 | +47.94% | 9M | +6.32% |
| Decreased Positions | 618 | -43.07% | 12M | -8.44% |
| New Positions | 199 | New | 2M | New |
| Sold Out Positions | 86 | Sold Out | 1M | Sold Out |
| Total Postitions | 1,505 | +4.88% | 137M | -2.12% |
| Vanguard Group Inc | $7.01M | 6.53% | 14.89M | -580,889 | -3.75% | 2025-09-30 |
| Blackrock, Inc. | $5.86M | 5.47% | 12.47M | -483,554 | -3.73% | 2025-09-30 |
| Sanders Capital, Llc | $5.02M | 4.68% | 10.68M | -426,920 | -3.85% | 2025-09-30 |
| State Street Corp | $3.52M | 3.29% | 7.49M | -466,059 | -5.86% | 2025-09-30 |
| Capital World Investors | $2.33M | 2.17% | 4.96M | +179,443 | +3.75% | 2025-09-30 |
| First Eagle Investment Management, Llc | $1.84M | 1.72% | 3.92M | -290,385 | -6.9% | 2025-09-30 |
| Wellington Management Group Llp | $1.83M | 1.7% | 3.88M | -230,117 | -5.6% | 2025-09-30 |
| Geode Capital Management, Llc | $1.72M | 1.6% | 3.65M | -147,762 | -3.89% | 2025-09-30 |
| Norges Bank | $1.41M | 1.32% | 3.01M | +208,560 | +7.45% | 2025-06-30 |
| Jpmorgan Chase & Co | $1.41M | 1.31% | 2.99M | -292,265 | -8.91% | 2025-09-30 |